Skip to main content
Version: 3.17

clingen-dosage-json

"clingenDosageSensitivityMap": [{
"chromosome": "15",
"begin": 30900686,
"end": 32153204,
"haploinsufficiency": "sufficient evidence suggesting dosage sensitivity is associated with clinical phenotype",
"triplosensitivity": "little evidence suggesting dosage sensitivity is associated with clinical phenotype",
"reciprocalOverlap": 0.00147,
"annotationOverlap": 0.33994
},
{
"chromosome": "15",
"begin": 31727418,
"end": 32153204,
"haploinsufficiency": "sufficient evidence suggesting dosage sensitivity is associated with clinical phenotype",
"triplosensitivity": "dosage sensitivity unlikely",
"reciprocalOverlap": 0.00147,
"annotationOverlap": 1
}]
FieldTypeNotes
clingenDosageSensitivityMapobject array
chromosomestringEnsembl-style chromosome names
begininteger1-based position
endinteger1-based position
haploinsufficiencystringsee possible values below
triplosensitivitystring(same as haploinsufficiency) 
reciprocalOverlapfloating pointRange: 0 - 1. E.g. 0.57 would indicate a 57% reciprocal overlap. Specified up to 5 decimal places (Not reported for Insertions).
annotationOverlapfloating pointRange: 0 - 1. E.g. 0.57 would indicate a 57% reciprocal overlap. Specified up to 5 decimal places (Not reported for Insertions).

haploinsufficiency and triplosensitivity

  • no evidence to suggest that dosage sensitivity is associated with clinical phenotype
  • little evidence suggesting dosage sensitivity is associated with clinical phenotype
  • emerging evidence suggesting dosage sensitivity is associated with clinical phenotype
  • sufficient evidence suggesting dosage sensitivity is associated with clinical phenotype
  • gene associated with autosomal recessive phenotype
  • dosage sensitivity unlikely